Table 3.

Urticaria activity score (mean) for the three patients at different times after receiving omalizumab.

Week of omalizumab	Patient 1	Patient 2	Patient 3
Week 0	8.52	8.48	7.61
Week 4	4.03	4.26	5.52
Week 8	2.16	2.19	3.35
Week 12	0.61	1.87	1.65
Week 16	0.23	0.26	1.61

P<.05 for comparison of week-to-week scores